https://biotechmorning.com/news/harrow-tyrvaya-nasal-spray-dry-eye-acquisition Biotech Morning en 2026-08-10T14:15:53.313Z The Dry Eye Drug That Ditched Eye Drops Entirely https://biotechmorning.com/news/actimed-recovers-cachexia-rights-faraday-collapse Biotech Morning en 2026-08-10T14:15:08.533Z When Your Partner Goes Broke, You Take the Keys Back https://biotechmorning.com/news/ensoma-running-out-of-lifelines Biotech Morning en 2026-08-10T14:14:23.027Z Ensoma Is Running Out of Lifelines https://biotechmorning.com/news/biotech-ipo-window-blossomhill-2026 Biotech Morning en 2026-08-10T14:13:40.988Z Biotech's IPO Window Just Cracked Wide Open https://biotechmorning.com/news/latigo-biotherapeutics-ipo-346-million Biotech Morning en 2026-08-10T14:12:59.450Z A Pain Startup Just Raised $346M on Day One. Here's Why Wall Street Showed Up. https://biotechmorning.com/news/icon-anthropic-claude-ai-clinical-trials Biotech Morning en 2026-08-10T14:12:13.208Z The Biggest CRO Just Handed Its Clinical Trials to an AI https://biotechmorning.com/news/repligen-biolife-solutions-acquisition-cell-therapy-2 Biotech Morning en 2026-08-10T14:11:31.912Z Repligen Just Bet $1.5 Billion on the Plumbing of Cell Therapy https://biotechmorning.com/news/supernus-indivior-merger-cns-powerhouse Biotech Morning en 2026-08-10T14:10:49.269Z Two Rivals Just Merged to Build a $2.2B Brain Drug Empire https://biotechmorning.com/news/eli-lilly-3-8-billion-psychedelics-atai-beckley Biotech Morning en 2026-08-10T14:09:57.237Z Eli Lilly Just Dropped $3.8 Billion on Psychedelics. Yes, Really. https://biotechmorning.com/news/fda-approves-bemotrizinol-first-new-sunscreen-ingredient-20-years-2 Biotech Morning en 2026-08-10T14:09:13.414Z America's Sunscreen Has Been Stuck Since the Late 1990s. That Just Changed. https://biotechmorning.com/news/pathos-ai-alphamab-astrazeneca-deals Biotech Morning en 2026-08-09T14:14:22.556Z Pathos AI Just Spent $2.2 Billion to Prove It's Not Just Another AI Hype Machine https://biotechmorning.com/news/tarsus-alkeus-800-million-stargardt-disease-deal Biotech Morning en 2026-08-09T14:13:36.321Z Tarsus Just Bet $800 Million on a Disease With Zero Treatments https://biotechmorning.com/news/circular-rna-in-vivo-car-t-ribox-fda-clearance Biotech Morning en 2026-08-09T14:12:52.925Z The CAR-T Hack That Skips the Factory Entirely https://biotechmorning.com/news/fda-casgevy-pediatric-sickle-cell-gene-therapy Biotech Morning en 2026-08-09T14:12:04.985Z A CRISPR Cure for Two-Year-Olds With Sickle Cell? The FDA Just Said Yes https://biotechmorning.com/news/intellia-crispr-liver-toxicity-root-cause Biotech Morning en 2026-08-09T14:11:19.467Z Intellia Says It Found the CRISPR Liver Toxicity Culprit. Now What? https://biotechmorning.com/news/lilly-ajax-jak-inhibitor-acquisition Biotech Morning en 2026-08-09T14:10:30.223Z Lilly Just Spent $2.3 Billion on a Drug Class With a Black Box Warning https://biotechmorning.com/news/argenx-forte-biosciences-acquisition-2-billion Biotech Morning en 2026-08-09T14:09:47.195Z argenx Just Dropped $2.2 Billion on a Company Most People Haven't Heard Of https://biotechmorning.com/news/lilly-kelonia-in-vivo-car-t-acquisition-2 Biotech Morning en 2026-08-09T14:09:00.311Z Lilly Just Dropped $7 Billion on a Cell Therapy That Skips the Factory https://biotechmorning.com/news/itc-investigation-china-biotech-subsidies Biotech Morning en 2026-08-09T14:08:13.451Z Uncle Sam Just Opened a File on China's Biotech Playbook